Smith Group Asset Management’s CONMED CNMD Stock Holding History

Smith Group Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$366K	Sell	2,462 -1,703	-41%	-$238K	0.02%	127
2021 Q4	$590K	Sell	4,165 -113	-3%	-$16K	0.03%	131
2021 Q3	$560K	Sell	4,278 -72	-2%	-$9.42K	0.03%	122
2021 Q2	$598K	Sell	4,350 -42	-1%	-$5.75K	0.03%	123
2021 Q1	$574K	Hold	4,392	–	–	0.03%	126
2020 Q4	$492K	Sell	4,392 -1,500	-25%	-$142K	0.03%	138
2020 Q3	$464K	Hold	5,892	–	–	0.02%	131
2020 Q2	$424K	Sell	5,892 -21	-0.4%	-$1.46K	0.02%	138
2020 Q1	$339K	Hold	5,913	–	–	0.02%	137
2019 Q4	$661K	Sell	5,913 -2,138	-27%	-$228K	0.03%	126
2019 Q3	$774K	Sell	8,051 -922	-10%	-$86.6K	0.03%	125
2019 Q2	$768K	Buy	8,973 +30	+0.3%	+$2.47K	0.03%	133
2019 Q1	$744K	Buy	+8,943	New	+$650K	0.02%	144

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Smith Group Asset Management's CNMD Position: Q1 2022 in Review

Smith Group Asset Management reduced its CONMED (CNMD) stake by 41% in Q1 2022, selling an estimated $238K and leaving 2,462 shares worth $366K. The position accounts for 0.02% of the portfolio, ranked #127.

Smith Group Asset Management first reported a position in CNMD in Q1 2019 and has held it in 13 quarters since. The position peaked at $774K in Q3 2019. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2022.

Smith Group Asset Management held 2,462 shares of CONMED worth $366K as of Q1 2022.
Smith Group Asset Management sold 1,703 CONMED shares in Q1 2022, an estimated $238K.
CONMED made up 0.02% of Smith Group Asset Management's portfolio in Q1 2022, its #127 holding.
Smith Group Asset Management first reported a position in CONMED in Q1 2019 and has held it in 13 quarters since.
Smith Group Asset Management's CONMED position peaked at $774K in Q3 2019.
280 funds tracked by Wall St. Rank held CONMED as of Q1 2022.

Based on Smith Group Asset Management's 13F filing for Q1 2022, filed 5 May 2022.